ÓÅÖÊ ¿ìË٠רҵ Áé»î
ÒÅ´«²¡
ÈËÀà»ùÒò×鼯»®¹À¼ÆÃ¿¸öÈË´óÔ¼ÓÐ2Íò¸ö»ùÒò£¬Ã¿¸ö»ùÒòΪ¸öÌå±£³ÖÕý³£¶ø²»Ð¸Å¬Á¦£¬µ«µ±µ¥¸ö»ùÒòÍ»±ä²¢ÒÅ´«¸øºó´úÒýÆð¼²²¡£¬¾ÍÊǵ¥»ùÒòÒÅ´«²¡£»¶øµ±ÏßÁ£ÌåÖеÄÒÅ´«ÐÅÏ¢¸Ä±ä´«µÝ¸øºó´ú¾ÍÊÇÏßÁ£Ìå¼²²¡¡£Ä¿Ç°µ¥»ùÒòÒÅ´«²¡·¢²¡Âʵͣ¬µ«ÖÖÀà¶àÇÒ´ó¶àÑÏÖØÎ£º¦¸öÌ壬ÉõÖÁÖ»û¡¢Ö²С¢ÖÂËÀ£»ÏßÁ£Ìå¼²²¡ÎªÄ¸ÏµÒÅ´«£¬Ò×ÒýÆð¸÷ÖÖÖ¢×´µÄ¼²²¡¡£Å·bao¡¤(Öйú)¹Ù·½ÍøÕ¾ÎªÒÅ´«²¡Ñо¿ÁìÓòÌṩ¸ßÆ·ÖÊ¡¢È«¶ÀÁ¢Ñз¢¡¢ÓµÓÐ×ÔÖ÷֪ʶ²úȨµÄÉÌÆ·»¯»ò¶¨ÖÆ»¯Panel£¬Îªµ¥»ùÒòÒÅ´«²¡µÄ»ù´¡Ñо¿»ò¼ì²âÌṩ¸ü¶à¿ÆÑ§¡¢È«ÃæµÄ˼·¡£
Ïà¹Ø²úÆ·
Core Exome
Kit
¸ÃPanelÓɲ®¿Æ¶À¼Ò¡°ÖÇÄÜÓ³É䡱Ëã·¨Éè¼ÆÍê³É£¬ÔÚ¸²¸Ç×î´ó»¯µÄͬʱÌá¸ßÖаÐÂÊ¡£¸ù¾Ý²®¿Æ´ó¹æÄ£¸ßͨÁ¿Éú²ú£¬¿É¼õÉÙÅú´ÎЧӦ£¬Ö÷Òª¸²¸ÇRefSeq¡¢CCDS¡¢ClinVarµÈ»ùÒòÊý¾Ý¿â19,524¸ö»ùÒò£¬Ô¼ÈËÀà»ùÒò×é34.1MÇøÓò¡£
Dominant Inherited
Disease Research
Panel
ÒÀÍв®¿Æ¸ßͨÁ¿ºËËáºÏ³ÉÒÔ¼°×ÔÖ÷֪ʶ²úȨµÄÉúÎïËØÐÞÊμ¼Êõ£¬TargetCap? Dominant Inherited Disease Research Panelº¬¸Ç30¸öÈËÀàÏÔÐÔÒÅ´«²¡»ùÒò¡£¸ÃPanelÓÉ1,607Ìõ̽Õë×é³É£¬¸²¸ÇÔ¼161KbÇø¼ä¡£Ì½ÕëŨ¶ÈÃ÷È·£¬¿É¶ÀÁ¢Ê¹Óã¬Ò²¿ÉÒÔ¼ÓÈëÆäËûpanelÁªºÏʹÓá£
Inherited Disease
Panel
²®¿ÆÉè¼ÆÉú²úµÄTargetCap? Inherited Disease Research Panel¸²¸Ç4611¸öÈËÀàÏÔÐÔÒÅ´«²¡Ïà¹Ø»ùÒò£¬ÓÉ119,880Ìõ̽Õë×é³É£¬Ì½Õ븲¸Ç13 MbÇø¼ä¡£Ì½ÕëŨ¶ÈÒÑÖª£¬¿É¶ÀÁ¢Ê¹Ó㬻ò¼ÓÈëÆäËû̽ÕëÅäºÏʹÓá£
Mitochondrion
Panel
Target Cap? Mitochondrion Panel ÓÉ137¸ö̽Õë×é³É£¬ÒÔʵÏÖÈ«³¤ÏßÁ£Ìå»ùÒò×é(16,571 bp)×î¼Ñ¸²¸Ç¡£¸ÃPanel¼È¿É¶ÀÁ¢Ê¹Óã¬ÓÖ¿É×÷Ϊһ¸öÄ£¿é¼ÓÈë¸öÐÔ»¯Panel½øÐÐÑо¿£¬ÇÒ²»Ó°Ïì¸öÐÔ»¯Panel¸÷ÏîÊý¾ÝÖ¸±ê¡£²»ÂÛÈçºÎʹÓã¬ÕûÌåÊý¾Ý¾ù±íÏÖÓÅÒ죬¸²¸Ç¾ùÒ»ÐԺ㬼ì²âÌØÒìÐԸߡ£
·þÎñÓÅÊÆ
´ÓÏîĿǢ̸µ½²úÆ·½»¸¶£¬²®¿Æ¼¼Êõר¼ÒÈ«³ÌΪ¿Í»§ÌṩÏîÄ¿×Éѯ£¬¸ßˮƽµÄ¿ÆÑ§×¨¼Ò½«Óë¿Í»§¹²Í¬Íê³ÉʵÑéÉè¼Æ¹¤×÷£¬´Ó¶øÈ·±£ÒÔ×îµÍµÄ³É±¾Íê³É¿Í»§µÄÏîĿĿ±ê¡£²®¿ÆÏîÄ¿¹ÜÀí»¹»áÿÖÜÓë¿Í»§×öÏîÄ¿¸üн»Á÷£¬ÒÔʹ¿Í»§Äܽ«Ö÷Òª¾«Á¦¼¯ÖÐÓÚ×ÔÉí¸ß¼ÛÖµ¹¤×÷¡£
¾Ñé·á¸»µÄÉúÎïÐÅϢѧ£¨BI£©×¨¼Ò°ïÖú¿Í»§Íê³ÉÏîĿĿ±ê¡£ÔÚ³õÆÚÏîÄ¿×ÉѯºÍÉè¼Æ¹ý³ÌÖУ¬²®¿ÆBIר¼Ò½«ÎªÄúÌṩÐÖú£¬Âú×ãÄúµÄ¾ßÌåÒªÇ󣬲¢ÌṩÃâ·ÑÊÛºó·þÎñ¡£
²®¿ÆÏîÄ¿¹ÜÀíС×齫ÔÚÊÕµ½ÄúÐèÇóºó24СʱÄÚ¸øÓè·´À¡¡£
·þÎñÁ÷³Ì
ÔÚÿ¸ö²½ÖèµÄ¹ý³ÌÖУ¬½øÐÐÑϸñµÄÖÊÁ¿¿ØÖÆ